FDA applicant

Upstream Peripheral Technologies

Philedelphia, PA5 decisions2012–20220 recalls

FDA records 5 decisions for Upstream Peripheral Technologies (Philedelphia, PA) from 2012 to 2022: 5 510(k) clearances. Most are in product codes DQY (Catheter, Percutaneous) and PDU (Catheter For Crossing Total Occlusions). Its devices cite 7 predicates, 1 of them its own earlier devices. No recall is linked to its devices.

FDA’s records also spell it “Upstream Peripheral Technologies, Ltd.”.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, cardiovascular panel, where it files most

How often FDA has decided Upstream Peripheral Technologies’s devices, and how often a recall has named them.

FDA decisions per year

1in 2022

2012high 3 (2012) · low 0 (2013)2026

2026 so far, outlined.

Recalls per year

No recall linked to its devices since 2012.

FIG. 1 — Upstream Peripheral Technologies by year, 2012–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Upstream Peripheral Technologies’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Upstream Peripheral Technologies

Which product codes does it file in?

Whose devices does it build on?

Which of its devices are cited most?

What has FDA decided for it lately?